The JP Morgan Healthcare Conference remains one of the most […]
As the pharmaceutical and biotech sectors advance, Contract Research Organizations […]
On July 30th, 2024, CMIC Group’s COO and President, Keiko […]
Decentralized clinical trials (DCTs) and Virtual Clinical Trials (VCTs) have […]
Entering the Japanese pharmaceutical market presents a lucrative opportunity for […]
In the ever-evolving landscape of healthcare, drug pricing and availability […]
Rare Disease Day, observed on the last day of February […]
As we step into 2024, the healthcare industry is undergoing […]
The Asia-Pacific (APAC) region has continued to thrive as a […]
This year marked the return of The Summit for Clinical […]
Japan has spent the last year and a half battling […]
Since its introduction in the 1980s, the market of orally […]
On March 10, 2021, CMIC Group in collaboration with RDD […]
Clinical drug development is a costly process that takes 10 […]
